We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$126M
AUM Growth
+$5.62M
Cap. Flow
+$1.04M
Cap. Flow %
0.83%
Top 10 Hldgs %
30.38%
Holding
118
New
6
Increased
43
Reduced
51
Closed
3

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$868K
2
MRK icon
Merck
MRK
+$703K
3
GE icon
GE Aerospace
GE
+$405K
4
CVS icon
CVS Health
CVS
+$388K
5
CTRA
Coterra Energy
CTRA
+$367K

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.49M
2
NXPI icon
NXP Semiconductors
NXPI
+$850K
3
INTC icon
Intel
INTC
+$330K
4
GILD icon
Gilead Sciences
GILD
+$291K
5
JWN
Nordstrom
JWN
+$242K

Sector Composition

Rank Sector Weight
1 Technology 15.33%
2 Financials 12.24%
3 Energy 11.01%
4 Healthcare 10.84%
5 Consumer Staples 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$635B
$1.6M 1.28%
17,772
+646
+4% +$56.4K
WY icon
27
Weyerhaeuser
WY
$17.6B
$1.6M 1.27%
53,253
+5,700
+12% +$176K
PFE icon
28
Pfizer
PFE
$144B
$1.5M 1.19%
48,555
+4,216
+10% +$129K
BEAV
29
DELISTED
B/E Aerospace Inc
BEAV
$1.43M 1.14%
23,800
-200
-0.8% -$11.5K
DD
30
DELISTED
Du Pont De Nemours E I
DD
$1.43M 1.14%
19,475
-175
-0.9% -$12.4K
SCHX icon
31
Schwab US Large- Cap ETF
SCHX
$71.3B
$1.41M 1.12%
158,778
+8,628
+6% +$74.9K
ABBV icon
32
AbbVie
ABBV
$469B
$1.09M 0.87%
17,495
+400
+2% +$24.4K
PCBK
33
DELISTED
Pacific Continental Corp
PCBK
$1.08M 0.86%
49,532
+3
+0% +$56
KO icon
34
Coca-Cola
KO
$378B
$1.07M 0.85%
25,744
+20,850
+426% +$868K
MOAT icon
35
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
$1.06M 0.85%
30,600
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.1T
$959K 0.76%
3,096
+50
+2% +$7.7K
BSV icon
37
Vanguard Short-Term Bond ETF
BSV
$44.7B
$903K 0.72%
11,373
+1,700
+18% +$136K
ATI icon
38
ATI
ATI
$25.3B
$886K 0.7%
55,667
+2,970
+6% +$49.3K
SCHA icon
39
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$866K 0.69%
56,352
+10,464
+23% +$154K
GS.PRK
40
DELISTED
GOLDMAN SACHS GROUP, INC. THE 6.375%
GS.PRK
$863K 0.69%
31,800
+1,600
+5% +$44.1K
VEU icon
41
Vanguard FTSE All-World ex-US ETF
VEU
$65.5B
$837K 0.67%
18,966
+138
+0.7% +$6.12K
SCHW.PRD
42
Charles Schwab 5.95% Series D Preferred Stock
SCHW.PRD
$719M
$826K 0.66%
33,080
+2,300
+7% +$59.7K
WM icon
43
Waste Management
WM
$96.4B
$801K 0.64%
11,310
-200
-2% -$13.4K
SCHM icon
44
Schwab US Mid-Cap ETF
SCHM
$14.5B
$792K 0.63%
52,689
+14,790
+39% +$216K
EMR icon
45
Emerson Electric
EMR
$84.3B
$790K 0.63%
14,184
+800
+6% +$43K
JWN
46
DELISTED
Nordstrom
JWN
$760K 0.6%
15,873
-4,450
-22% -$242K
WMB icon
47
Williams Companies
WMB
$85.5B
$754K 0.6%
24,215
-400
-2% -$12.1K
FDX icon
48
FedEx
FDX
$73.7B
$738K 0.59%
3,965
+730
+23% +$134K
WFC.PRR
49
DELISTED
WELLS FARGO & COMPANY Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series R
WFC.PRR
$726K 0.58%
26,800
+900
+3% +$25.4K
WFC icon
50
Wells Fargo
WFC
$263B
$719K 0.57%
13,051
-750
-5% -$37.7K

Similar funds

Mengis Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Mengis Capital Management held 118 positions worth $126M, up 4.7% from $120M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Mengis Capital Management's Q4 2016 filing shows 6 new, 43 increased, 51 reduced and 3 closed positions. Its largest new stake was CVS Health: 4,800 shares worth $378K. The largest sale was Allergan Inc, an estimated $1.49M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Energy.

  • Mengis Capital Management's largest Q4 2016 buy was CVS Health: 4,800 shares worth $378K.
  • Mengis Capital Management added most to Coca-Cola in Q4 2016, an estimated $868K increase.
  • Mengis Capital Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $850K.
  • Mengis Capital Management fully exited Allergan Inc in Q4 2016, selling an estimated $1.49M.
  • Mengis Capital Management's ten largest holdings make up 30% of its $126M portfolio in Q4 2016.
  • Mengis Capital Management opened 6 new positions and closed 3 in Q4 2016.
  • Mengis Capital Management's portfolio value rose 4.7% quarter-over-quarter to $126M.

Based on Mengis Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.